Home › Melanoma › Florida › Orlando
Pag-aaral pangklinika para sa Melanoma sa Orlando, FL
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi ang layo
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Nagre-recruitPhase 2
- Nemours Children's Hospital, Orlando
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Nagre-recruitPhase 3
- Orlando Health Cancer Institute, Orlando
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Orlando Health Cancer Institute, Orlando
- Health Central, Ocoee · 10 mi ang layo
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Nagre-recruitPhase 1
- AdventHealth, Orlando
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Nagre-recruitPhase 2
- Orlando Health Cancer Institute, Orlando
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Nagre-recruitPhase 1
- Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- AdventHealth Orlando, Orlando
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- AdventHealth Celebration, Celebration · 17 mi ang layo
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
- Clermont Oncology Center, Clermont · 24 mi ang layo
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Nagre-recruitPhase 1
- Florida Cancer Specialists - Lake Nona, Orlando
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Nagre-recruitPhase 1/2
- Orlando Health Cancer Institute, Orlando
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Nagre-recruitPhase 3
- Orlando Health Cancer Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mi ang layo
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN32 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Atlanta, GA21 pag-aaral
- Columbus, OH21 pag-aaral
- Salt Lake City, UT21 pag-aaral
- Durham, NC21 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer44 pag-aaral
- Metastatic Cancer29 pag-aaral
- Obesity29 pag-aaral
- Kanser (lahat ng uri)25 pag-aaral
- Sakit ni Alzheimer25 pag-aaral
- Overweight25 pag-aaral
- Type 2 Diabetes24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Ulcerative Colitis23 pag-aaral
- Kanser sa Ovary22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Colorectal Cancer19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.